Web site is worth a read
https://neuroscientific.com/our-science/
Biopharmaceutical innovation and world class R&DNSB (ASX:NSB) is a drug development company focused on developing peptide-based pharmaceutical drugs for the treatment of neurodegenerative conditions with high unmet medical need.The NSB product portfolio includes several therapeutic peptides that are modeled on the domains of a naturally occurring protein called Metallothionein-II (MT-II).EmtinB is the lead candidate that has shown to closely mimic the neuroprotective and neuroregenerative ability of MT-II.
EmtinB is currently being developed as a treatment for neurodegenerative dementia and Alzheimer’s disease, and degenerative conditions of the optic nerve.
Web site is worth a...
Add NSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
-0.001(2.00%) |
Mkt cap ! $7.086M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.9¢ | $9.09K | 183.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.1¢ | 75976 | 1 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.0¢ |
Change
-0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 5.0¢ | 5.0¢ | 5.0¢ | 3068 | ||
| Last updated 11.20am 31/05/2024 ? | |||||
| NSB (ASX) Chart |